Dominari Holdings Inc
DOMH
Get informed when a big investor buys or sells
+ FollowMarket Cap$40.91M
Close$
$2.59
1.3% upside
Current Fair Value
1.3% upsideUndervalued by 1.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $40.91 Million |
|---|---|
| Enterprise Value | $36.35 Million |
| Dividend Yield | $0.96 (37.90%) |
| Earnings per Share | $-1.57 |
| Beta | 0.83 |
| Outstanding Shares | 18,068,269 |
Return
| Return on Equity | -149.66% |
|---|---|
| Return on Assets | -55.44% |
| Return on Invested Capital | 101.68% |
Valuation & Multiples
| P/E Ratio | -1.19 |
|---|---|
| PEG | -1.55 |
| Price to Sales | 0.32 |
| Price to Book Ratio | 2.56 |
| Enterprise Value to Revenue | 0.24 |
| Enterprise Value to EBIT | 0.55 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.63 |
| Debt to Equity | 0.73 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$30.08 M
Average shareholder expectationNext Earnings Call
Expected Date
August 18, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$30.08 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 25,200▼ 69.57% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 8.89%▼ 2.12% |
|---|---|
| Total Invested | $5.22M▼ 32.53% |
| Investors Holding | 31▼ 9.00% |
ESG Score
No data
About Dominari Holdings Inc
5 employees
CEO: Anthony Hayes AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and res...